Advancing Multidisciplinary Care in Cutaneous Squamous Cell Carcinoma
*To be eligible to attend this meeting, clinicians must be a practicing dermatologist or medical oncologist in the US.
Objectives:
- Evaluate the efficacy and safety of treatments in advanced cutaneous squamous cell carcinoma (CSCC), including appropriate patient selection and real-world considerations for dermatology practice - Define the roles of dermatologists and oncologists, including referrals, co-management strategies, and transitions of care in both advanced and perioperative settings - Apply evidence-based strategies for adverse event recognition and management, as well as ongoing patient monitoring
MEETING DETAILS
DATE & TIME
June 23, 2026
6:30 PM - 8:30 PM CT
EVENT VENUE
Ruth's Chris Steak House (Ruth Room)
17840 Dallas Parkway
Dallas, TX
MARKET RESEARCH PARTICIPATION
Healthcare Research & Analytics offers compensation of $750 to dermatologists and medical oncologists for their consultative insights during the forum's discussions, responses to polling questions and completion of a postevent survey.
Your feedback provides HRA® with a pulse on physicians’ educational needs in a regional event.
Participants must be a dermatologist or dermatology clinician currently treating patients in a community practice setting.
Seating is limited, and registration will close when capacity is reached.
Dermatology Times® — an MJH Life Sciences Brand
Copyright 2025 © Multimedia Healthcare Communications, LLC. All Rights Reserved.